Longevity · Longevity peptide (research)
NAD+
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Also known as
- nad, nad plus, nicotinamide adenine dinucleotide, nmn, nr, nicotinamide
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What NAD+ is studied for
- Mitochondrial energy (research)
- Cellular repair (research)
- Cognitive clarity (research)
Mechanism of action
NAD+ is being studied in the longevity category. Coenzyme essential to mitochondrial energy and cellular repair. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is NAD+?
NAD+ is a longevity peptide. Coenzyme essential to mitochondrial energy and cellular repair.
What is NAD+ studied for?
Published research has examined NAD+ for mitochondrial energy, cellular repair, cognitive clarity. Human clinical evidence varies by indication.
Is NAD+ FDA-approved?
No. NAD+ is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is NAD+ used in research?
Protocols vary by study. NAD+ is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for NAD+ is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.